Abnova Taiwan Corp (4133) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Abnova Taiwan Corp (4133) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$3.16 Million ≈ $99.59K USD) by net assets (NT$1.24 Billion ≈ $39.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Abnova Taiwan Corp - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Abnova Taiwan Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Abnova Taiwan Corp carry for a breakdown of total debt and financial obligations.

Abnova Taiwan Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Abnova Taiwan Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hsinjing Holding Co Ltd TWO:3713	0.028x
TWL Holdings Bhd KLSE:7079	-0.025x
Persimmon PLC LSE:PSN	-0.031x
Koss Corporation NASDAQ:KOSS	-0.025x
Koge Micro Tech Co Ltd TWO:4568	0.035x
Lite Strategy, Inc. NASDAQ:LITS	-0.040x
First Graphene Ltd F:M11	-0.111x
Cypress Technology Co Ltd TWO:3541	0.021x

Annual Cash Flow Conversion Efficiency for Abnova Taiwan Corp (2009–2024)

The table below shows the annual cash flow conversion efficiency of Abnova Taiwan Corp from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see Abnova Taiwan Corp (4133) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$1.31 Billion ≈ $41.25 Million	NT$50.85 Million ≈ $1.60 Million	0.039x	-34.46%
2023-12-31	NT$1.29 Billion ≈ $40.53 Million	NT$76.22 Million ≈ $2.40 Million	0.059x	-42.17%
2022-12-31	NT$1.29 Billion ≈ $40.70 Million	NT$132.37 Million ≈ $4.17 Million	0.102x	+33.67%
2021-12-31	NT$1.21 Billion ≈ $38.18 Million	NT$92.88 Million ≈ $2.93 Million	0.077x	-11.85%
2020-12-31	NT$1.21 Billion ≈ $38.16 Million	NT$105.30 Million ≈ $3.32 Million	0.087x	+39.14%
2019-12-31	NT$1.19 Billion ≈ $37.57 Million	NT$74.51 Million ≈ $2.35 Million	0.062x	-13.99%
2018-12-31	NT$1.23 Billion ≈ $38.66 Million	NT$89.17 Million ≈ $2.81 Million	0.073x	+31.77%
2017-12-31	NT$1.22 Billion ≈ $38.59 Million	NT$67.53 Million ≈ $2.13 Million	0.055x	-9.84%
2016-12-31	NT$1.18 Billion ≈ $37.06 Million	NT$71.94 Million ≈ $2.27 Million	0.061x	-2.83%
2015-12-31	NT$1.17 Billion ≈ $36.76 Million	NT$73.43 Million ≈ $2.31 Million	0.063x	-17.82%
2014-12-31	NT$1.23 Billion ≈ $38.74 Million	NT$94.18 Million ≈ $2.97 Million	0.077x	-14.21%
2013-12-31	NT$1.23 Billion ≈ $38.74 Million	NT$109.78 Million ≈ $3.46 Million	0.089x	+44.31%
2012-12-31	NT$1.23 Billion ≈ $38.72 Million	NT$76.02 Million ≈ $2.40 Million	0.062x	-41.44%
2011-12-31	NT$1.27 Billion ≈ $40.03 Million	NT$134.22 Million ≈ $4.23 Million	0.106x	+17.26%
2010-12-31	NT$1.27 Billion ≈ $40.01 Million	NT$114.40 Million ≈ $3.60 Million	0.090x	+71.09%
2009-12-31	NT$1.21 Billion ≈ $38.13 Million	NT$63.72 Million ≈ $2.01 Million	0.053x	--

About Abnova Taiwan Corp

TW:4133 Taiwan Biotechnology

Market Cap

$41.21 Million

NT$1.31 Billion TWD

Market Cap Rank

#22591 Global

#1410 in Taiwan

Share Price

NT$21.60

Change (1 day)

-0.69%

52-Week Range

NT$21.60 - NT$33.90

All Time High

NT$149.53